Sarah Townsend

PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer

Waheeda Owadally, Chris Hurt, Hayley Timmins et al. · BMC Cancer · 2015 · 263 citations · Full text

Medicine, Oncology, Oral Surgery +17

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

Philip N. Newsome, Richard Fox, Andrew King et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 159 citations · Full text

Medicine, Hematology, Immunology +16

The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis

Heidi Schilter, Alison D. Findlay, Lara Perryman et al. · Journal of Cellular and Molecular Medicine · 2018 · 114 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

David J. Pinato, Daniela Ferrante, Georgina Hanbury et al. · The Lancet Oncology · 2022 · 80 citations · Full text

Medicine, Infectious Diseases, Oncology +16

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

Alessio Cortellini, Josep Tabernero, Uma Mukherjee et al. · The Lancet Oncology · 2023 · 34 citations · Full text

Veterinary Medicine, Infectious Diseases, Oncology +12